Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373391.RAeAAGcnZAAOU2l1oOwZ2ZEcQhDZ2wX5aLekVhAFPYMck130_provenance.
• NP376319.RAey4ATBAr7j3X1eOKFMW536sUYKMFmvErTWgXLhxid9c130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376319.RAey4ATBAr7j3X1eOKFMW536sUYKMFmvErTWgXLhxid9c130_provenance.
• NP698038.RAatWSxWF7Ot9jAOk552LjgAhsPXEjUrwxs7_dIr6LKcQ130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698038.RAatWSxWF7Ot9jAOk552LjgAhsPXEjUrwxs7_dIr6LKcQ130_provenance.
• NP698053.RASjO_S8aW74jueujl2Qy8LlyNsl79RerzXxi4v9FRK2s130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698053.RASjO_S8aW74jueujl2Qy8LlyNsl79RerzXxi4v9FRK2s130_provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP670474.RAaZTcSWbJqjl_EzDdIezggHpTM-ssIMra0RkiXY7iv5s130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670474.RAaZTcSWbJqjl_EzDdIezggHpTM-ssIMra0RkiXY7iv5s130_provenance.
• NP670471.RAtDYU-PhhTf0AjQGf6iMYZyoXUb0y6IfJCe0OQ4VP0Sk130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670471.RAtDYU-PhhTf0AjQGf6iMYZyoXUb0y6IfJCe0OQ4VP0Sk130_provenance.
• NP373380.RAJhrUBxPOaFVM4IB_l5XibMksBEctoNJG30CVwSKFue0130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373380.RAJhrUBxPOaFVM4IB_l5XibMksBEctoNJG30CVwSKFue0130_provenance.
• NP376326.RAEwpU5ikaqj97uQtNxxzmfYb4N7NU5AeWAmz54iYlDf4130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376326.RAEwpU5ikaqj97uQtNxxzmfYb4N7NU5AeWAmz54iYlDf4130_provenance.
• NP670470.RA1gPvMU2GP-7xYc6D91KgM6n6T-97-dBKfjHaTKBqMX4130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670470.RA1gPvMU2GP-7xYc6D91KgM6n6T-97-dBKfjHaTKBqMX4130_provenance.
• NP670472.RA5oxLras6L8Y5BjpUejNfTo6UaeWOvZpfroOLlpNFsGo130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670472.RA5oxLras6L8Y5BjpUejNfTo6UaeWOvZpfroOLlpNFsGo130_provenance.
• NP670473.RAzFcMXkuAPMeMeeKscOZtNKi72l6kf6GVZSdzTJ_YC_U130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670473.RAzFcMXkuAPMeMeeKscOZtNKi72l6kf6GVZSdzTJ_YC_U130_provenance.
• NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_assertion description "[SCLC is the most common BP-NET, while LCNEC is rare, approximately 10% and < or =1%, respectively, of all lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670475.RAzF1t1e2cAyP7cL8zThtyzFnBhvOVI0Yvc9HtaM6BbNM130_provenance.